Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom.

Journal of clinical microbiology - 1 Jul 2001

Cane P A, de Ruiter A, Rice P, Wiselka M, Fox R, Pillay D

Abstract excerpt

This work reports the variability of human immunodeficiency virus type 1 (HIV-1) protease from treated and untreated patients infected with HIV-1 subtype C in the United Kingdom. The most common primary mutation observed in treated patients was L90M. D30N, M46I, V82A/F, and I84V were seen rarely. M36I and I93L mutations were observed in nearly all samples from both treated and untreated patients and so cannot be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diseases in Twins
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to United Kingdom

Source

Open in PubMed Open full text

Identifiers

PMID: 11427587
DOI: 10.1128/JCM.39.7.2652-2654.2001
PMCID: PMC88203

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom.PMID 11427587Read ↗

Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor.Semantic proximity Read ↗

Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India.Semantic proximity Read ↗

Emergence of drug resistance-associated mutations in HIV-1 subtype C protease gene in north India.Semantic proximity Read ↗

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom.Semantic proximity Read ↗

Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.Semantic proximity Read ↗

Drug Resistance-Associated Genotypic Alterations in the <i>pol</i> Gene of HIV Type 1 Isolates in ART-Naive Individuals in North IndiaSemantic proximity Read ↗

Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.Semantic proximity Read ↗

Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy.Semantic proximity Read ↗

In vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir.Semantic proximity Read ↗

Genotypic resistance profile of HIV-1 protease gene: a preliminary report from Vellore, south India.Semantic proximity Read ↗

Polymorphism and Drug-Selected Mutations in the Protease Gene of Human Immunodeficiency Virus Type 2 from Patients Living in Southern FranceSemantic proximity Read ↗

Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.